IMAX Corporation financials

  1. Home
  2. Financials
  3. IMAX
IMAX CIK 0000921582

Source: EDGAR filings · Built 2026-06-02T03:18:23Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 118.90M 61.90M 51.64M 7.95M 2.48M -23.71M
EBITDA 146.68M 109.36M 110.42M 51.83M 67.07M -68.22M
Net Debt 138.51M 177.53M 189.07M 181.27M 51.09M 4.93M
Gross Margin 60.02% 54.00% 57.18% 51.98% 52.73% 15.72%
Operating Margin 20.53% 12.45% 13.45% -1.61% 4.31% -88.92%
Net Margin 8.50% 7.40% 6.76% -7.58% -8.76% -104.94%
Return on Equity (ROE) 10.32% 8.70% 9.28% -8.66% -6.27% -36.49%
Return on Assets (ROA) 3.90% 3.14% 3.11% -2.78% -2.53% -14.41%
Debt-to-Equity 0.86× 0.93× 0.97× 1.06× 0.68× 0.82×
Effective Tax Rate 28.07% 13.25% 28.30% -103.47% 187.17% -20.53%
Cash Conversion Ratio 3.64× 2.72× 2.31× -0.76× -0.27× 0.16×
Accruals Ratio -0.10× -0.05× -0.04× -0.05× -0.03× -0.12×
SBC % of Revenue 6.48% 6.47% 6.30% 8.98% 10.04% 15.69%
CapEx Coverage 15.56× 7.93× 8.41× 1.85× 1.69× -33.01×
Free Cash Flow Per Share $2.14 $1.15 $0.94 $0.14 $0.04 $-0.40

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 58.67× 53.33× 32.65× — — —
P/FCF 17.27× 22.28× 16.04× 104.49× 425.78× —
FCF Yield 5.79% 4.49% 6.24% 0.96% 0.23% —
EV / EBITDA 14.53× 14.02× 8.96× 18.81× 16.36× —
P/S 4.86× 3.85× 2.13× 2.64× 4.11× 7.75×
P/B 5.90× 4.53× 2.93× 3.01× 2.94× 2.69×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 410.21M 352.21M 374.84M 300.81M 254.88M 137.00M
Revenues 410.21M 352.21M 374.84M 300.81M 254.88M 137.00M
Cost of Goods and Services Sold 164.02M 162.01M 160.50M 144.45M 120.48M 115.46M
Cost of Revenue — — — — — 35.68M
Gross Profit 246.19M 190.20M 214.34M 156.35M 134.41M 21.54M
Research and Development Expense 5.82M 5.10M 10.11M 5.30M 6.94M 5.62M
Selling, General and Administrative Expense 138.46M 132.70M 144.41M 138.04M 117.32M 108.48M
Operating Income (Loss) 84.23M 43.86M 50.40M -4.83M 10.98M -121.82M
Income Tax Expense (Benefit) 17.77M 5.00M 13.05M 10.11M 20.56M 26.50M
Net Income (Loss) Attributable to Parent 34.88M 26.06M 25.34M -22.80M -22.33M -143.78M
Earnings Per Share, Basic $0.65 $0.49 $0.47 $-0.40 $-0.38 $-2.43
Weighted Average Number of Shares Outstanding, Basic 53.64M 52.65M 54.31M 56.67M 59.13M 59.24M
Earnings Per Share, Diluted $0.63 $0.48 $0.46 $-0.40 $-0.38 $-2.43
Weighted Average Number of Shares Outstanding, Diluted 55.54M 53.86M 55.15M 56.67M 59.13M 59.24M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 151.17M 100.59M 76.20M 97.40M 189.71M 317.38M
Assets 894.03M 830.40M 814.67M 821.15M 883.25M 997.75M
Long-term Debt — — — — 2.47M 305.68M
Liabilities 466.30M 452.18M 469.08M 491.39M 452.88M 532.98M
Stockholders' Equity Attributable to Parent 337.89M 299.47M 273.14M 263.36M 356.08M 394.00M
Common Stock, Shares, Outstanding 53.92M 52.95M 53.26M 54.15M 58.65M 58.92M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 127.07M 70.84M 58.62M 17.32M 6.07M -23.01M
Payments to Acquire Property, Plant, and Equipment 8.17M 8.43M 6.49M 8.42M 3.59M 697.00K
Net Cash Provided by (Used in) Investing Activities -41.92M -41.22M -31.79M -53.29M -7.00K -9.26M
Payments for Repurchase of Common Stock — — — — 13.90M 36.62M
Net Cash Provided by (Used in) Financing Activities -34.08M -6.04M -48.53M -58.51M -132.72M 240.57M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (IMAX CIK 0000921582), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

KALV

KalVista Pharmaceuticals, Inc.

SLGN

SILGAN HOLDINGS INC

BWMN

BOWMAN CONSULTING GROUP LTD.